Entecavir for the treatment of chronic hepatitis B virus infection.
about
Antiviral drugs for viruses other than human immunodeficiency virusEfficacy of initial treatment with clevudine in naive patients with chronic hepatitis BTelaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy.Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infectionsEfficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.Adverse effects of oral antiviral therapy in chronic hepatitis B.Hepatitis B virus infection in children.Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication.Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model.Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug-Drug InteractionsEntecavir treatment in kidney transplant recipients infected with hepatitis B.Comprehensive treatment of acute-on-chronic liver failure in a patient with hepatitis B: a case report.Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.LC-MS/MS method for the characterization of the forced degradation products of Entecavir.
P2860
Q24635330-C9AD3AC2-15A4-4562-BA8B-C3020E944CCBQ34385005-446706DD-B11B-41EC-B8F9-12310D51B772Q35607785-2394171D-72E0-49B3-B9BE-F03774D7963BQ36244591-7F4EDD9D-D4A1-4F12-AC20-7AE5F42F09EEQ36314573-E0C35E22-4837-41DC-BE40-C7666B32F096Q37138794-02FE45D5-CB6E-4532-A10F-13AA2C9DA718Q37644005-4A44FC63-38F0-4166-9969-C6FC75E41A05Q37651892-43E19874-2BDB-497B-8410-886E94D27A30Q38365905-D42E208A-F7EF-428A-AE9B-3D068796FBDCQ39277056-71B7AF13-1F2E-493E-BBC9-115F70DCFBC6Q40706082-319ED74A-2DAE-4FFB-893D-F7A2D9CF6268Q40829113-501B2DB4-3283-4519-81A5-E4882113682FQ42209408-4941E358-E7B7-4286-96B3-B61E6EE2A49EQ42219823-4BC5F42D-A003-44DF-8EA7-54F950D90620Q42248312-A8AD8106-B3C9-4224-A55A-CE769E2A9043Q53098576-159C3578-1E44-4CB8-8744-357DB7E11C50
P2860
Entecavir for the treatment of chronic hepatitis B virus infection.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Entecavir for the treatment of chronic hepatitis B virus infection.
@ast
Entecavir for the treatment of chronic hepatitis B virus infection.
@en
type
label
Entecavir for the treatment of chronic hepatitis B virus infection.
@ast
Entecavir for the treatment of chronic hepatitis B virus infection.
@en
prefLabel
Entecavir for the treatment of chronic hepatitis B virus infection.
@ast
Entecavir for the treatment of chronic hepatitis B virus infection.
@en
P1476
Entecavir for the treatment of chronic hepatitis B virus infection.
@en
P2093
S James Matthews
P304
P356
10.1016/J.CLINTHERA.2006.02.012
P577
2006-02-01T00:00:00Z